Campuzano MG

Language: Spanish
References: 409
Page: 111-152
PDF size: 2189.47 Kb.

ABSTRACT

Thrombocytopenia represents the most common finding in acquired hemorrhagic diseases. As it happens with anemia and hypertension, it is not considered a disease but a sign that expresses itself both in the clinical and in the laboratory setting. The clinician must define the disease which is being expressed by the sign through complementary studies performed according with the clinic, and offer an adequate and timely treatment. Four thrombocytopenic groups are defined: 1) induced by a reduced production of platelets, 2) induced by a shortening in the half-life of platelets, 3) induced by sequestration of platelets, and 4) induced by hemodilution. An analysis of the clinical manifestations in the most common thrombocytopenic diseases is performed.

REFERENCES

1. Campuzano-Maya G. El hemograma electrónico. Laboratorio al Día 1995; 5: 28-41.

2. Briggs C, Harrison P, Grant D, Staves J, MacHin SJ. New quantitative parameters on a recently introduced automated blood cell counter--the XE 2100. Clin Lab Haematol 2000; 22: 345-350.

3. Briggs C, Kunka S, Machin SJ. The most accurate platelet count on the Sysmex XE-2100. Optical or impedance? Clin Lab Haematol 2004; 26: 157-158.

4. Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int Jnl Lab Hem 2007; 29: 77-91.

5. Campuzano-Maya G. Estudio del paciente con trombocitopenia. Laboratorio al Día 1995; 5: 325-350.

6. Orozco-Rojas CA, Aguirre-Jaramillo OH. Trombocitopenia multifactorial en los recién nacidos hospitalizados en unidades de cuidados intensivos neonatales. Medicina & Laboratorio 2005; 11: 177-194.

7. Hartwig JH, Italiano JE. Life of the Blood Platelet. In Blood: Principles and practice of hematology, Handin RI, Lux SE and Stossel TP. Lippincott Williams & Wilkins, Philadelphia, P.A. 2003; 1049-1079.

8. Ferguson JJ. The physiology of normal platelet function. In Antiplatelet therapy in clinical practice, Ferguson JJ, Chronos N and Harrington RA. Martin Dunitz, London. 2000; 15-35.

9. George JN. Platelets. Lancet 2000; 355: 1531-1539.

10. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.

11. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596.

12. Teo CP, Kueh YK. Incidence of thrombocytopenia in an acute care hospital. Ann Acad Med Singapore 1989; 18: 379-381.

13. Hanes SD, Quarles DA, Boucher BA. Incidence and risk factors of thrombocytopenia in critically ill trauma patients. Ann Pharmacother 1997; 31: 285-289.

14. Crowther MA, Cook DJ, Meade MO, Griffith LE, Guyatt GH, Arnold DM, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care 2005; 20: 348-353.

15. Sociedad Colombiana de Patología Clínica. Manual de Codificación, Nomenclatura, Nivelación y Valores de Exámenes de laboratorio Clínico. 2007; Editora Médica Colombiana S.A., Edimeco, Medellín, Colombia. 1-52.

16. República de Colombia, Ministerio de Salud. Resolución No. 1896 de 2001. Por la cual se sustituye la Clasificación Única de Procedimientos en Salud.

17. Laboratorio Clínico Hematológico S.A. Manual de Procedimientos. Sistema de Integrado de Gestión. 2007. Medellín, Colombia.

18. Hall JG, Levin J, Kuhn JP, Ottenheimer EJ, van Berkum KA, McKusick VA. Thrombocytopenia with absent radius (TAR). Medicine (Baltimore) 1969; 48: 411-439.

19. Mhawech P, Saleem A. Inherited giant platelet disorders. Classification and literature review. Am J Clin Pathol 2000; 113: 176-190.

20. Geddis AE. Inherited thrombocytopenia: Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Semin Hematol 2006; 43: 196-203.

21. Hedberg VA, Lipton JM. Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol 1988; 10: 51-64.

22. Luthy DA, Mack L, Hirsch J, Cheng E. Prenatal ultrasound diagnosis of thrombocytopenia with absent radii. Am J Obstet Gynecol 1981; 141: 350-351.

23. Donnenfeld AE, Wiseman B, Lavi E, Weiner S. Prenatal diagnosis of thrombocytopenia absent radius syndrome by ultrasound and cordocentesis. Prenat Diagn 1990; 10: 29-35.

24. Labrune P, Pons JC, Khalil M, Mirlesse V, Imbert MC, Odievre M, et al. Antenatal thrombocytopenia in three patients with TAR (thrombocytopenia with absent radii) syndrome. Prenat Diagn 1993; 13: 463-466.

25. Warkentin TE, Kelton JG. Platelet life cycle: Quantitative disorders. In Blood: Principles and practice of hematology, Handin RI, Lux SE and Stossel TP. Lippincott Williams & Wilkins, Philadelphia, P.A. 2003; 983-1047.

26. Fanconi G. Familial constitutional panmyelocytopathy, Fanconi’s anemia (F.A.). I. Clinical aspects. Semin Hematol 1967; 4: 233-240.

27. Gordon-Smith EC, Rutherford TR. Fanconi anaemia--constitutional, familial aplastic anaemia. Baillieres Clin Haematol 1989; 2: 139-152.

28. Sieff CA, Nisbet-Brown E, Nathan DG. Congenital bone marrow failure syndromes. Br J Haematol 2000; 111: 30-42.

29. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2: 446-457.

30. Van den Oudenrijn S, Bruin M, Folman CC, Peters M, Faulkner LB, de Haas M, et al. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol 2000; 110: 441-448.

31. Hayashi T, Suzuki K. Molecular pathogenesis of Bernard- Soulier syndrome. Semin Thromb Hemost 2000; 26: 53-59.

32. King S, Germeshausen M, Strauss G, Welte K, Ballmaier M. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients. Br J Haematol 2005; 131: 636-644.

33. Passos-Coelho JL, Sebastiao M, Gameiro P, Reichert A, Vieira L, Ferreira I, et al. Congenital amegakaryocytic thrombocytopenia-Report of a new c-mpl gene missense mutation. Am J Hematol 2007; 82: 240-241.

34. Al-Ahmari A, Ayas M, Al-Jefri A, Al-Mahr M, Rifai S, El-Solh H. Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT). Bone Marrow Transplant 2004; 33: 829-831.

35. Drachman JG, Jarvik GP, Mehaffey MG. Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood 2000; 96: 118-125.

36. Sheth NK, Prankerd TA. Inherited thrombocytopenia with thrombasthenia. J Clin Pathol 1968; 21: 154-156.

37. Tonelli R, Strippoli P, Grossi A, Savoia A, Iolascon A, Savino M, et al. Hereditary thrombocytopenia due to reduced platelet production--report on two families and mutational screening of the thrombopoietin receptor gene (c-mpl). Thromb Haemost 2000; 83: 931-936.

38. Diamandis M, Adam F, Kahr WH, Wang P, Chorneyko KA, Arsenault AL, et al. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis. J Thromb Haemost 2006; 4: 1086-1094.

39. Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, et al. Pseudo-von Willebrand’s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 306: 326-333.

40. Hultin MB, Sussman, II. Postoperative thrombocytopenia in type IIB von Willebrand disease. Am J Hematol 1990; 33: 64-68.

41. Donner M, Holmberg L, Nilsson IM. Type IIB von Willebrand’s disease with probable autosomal recessive inheritance and presenting as thrombocytopenia in infancy. Br J Haematol 1987; 66: 349-354.

42. Thompson AR, Wood WG, Stamatoyannopoulos G. Xlinked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood 1977; 50: 303-316.

43. Raskind WH, Niakan KK, Wolff J, Matsushita M, Vaughan T, Stamatoyannopoulos G, et al. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia. Blood 2000; 95: 2262-2268.

44. Ho CY, Otterud B, Legare RD, Varvil T, Saxena R, DeHart DB, et al. Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2. Blood 1996; 87: 5218-5224.

45. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166-175.

46. Ducrou W, Kimber RJ. Stomatocytes, haemolytic anaemia and abdominal pain in Mediterranean migrants. Some examples of a new syndrome? Med J Aust 1969; 2: 1087-1091.

47. Pembrey RG, Handley DA, Kimber RJ. Causes of thrombocytopenia in a hospital population. A six-months survey of 7,750 patients. Med J Aust 1971; 1: 583-588.

48. Von Behrens WE. Mediterranean macrothrombocytopenia. Blood 1975; 46: 199-208.

49. Rees DC, Iolascon A, Carella M, O’Marcaigh A S, Kendra JR, Jowitt SN, et al. Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia. Br J Haematol 2005; 130: 297-309.

50. Stewart GW, Lloyd J, Pegel K. Mediterranean stomatocytosis/ macrothrombocytopenia: update from Adelaide, Australia. Br J Haematol 2006; 132: 660-661.

51. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998; 104: 355-360.

52. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69: 1033-1045.

53. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, et al. Hereditary macrothrombocytopathia, nephritis and deafness. Am J Med 1972; 52: 299-310.

54. Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82: 203-215.

55. Peterson LC, Rao KV, Crosson JT, White JG. Fechtner syndrome--a variant of Alport’s syndrome with leukocyte inclusions and macrothrombocytopenia. Blood 1985; 65: 397-406.

56. Greinacher A, Bux J, Kiefel V, White JG, Mueller-Eckhardt C. May-Hegglin anomaly: a rare cause of thrombocytopenia. Eur J Pediatr 1992; 151: 668-671.

57. Campuzano-Maya G. Alteraciones del hemograma relacionadas con los contadores de células. Medicina & Laboratorio 2005; 11: 363-384.

58. Greinacher A, Mueller-Eckhardt C. Hereditary types of thrombocytopenia with giant platelets and inclusion bodies in the leukocytes. Blut 1990; 60: 53-60.

59. Heynen MJ, Blockmans D, Verwilghen RL, Vermylen J. Congenital macrothrombocytopenia, leucocyte inclusions, deafness and proteinuria: functional and electron microscopic observations on platelets and megakaryocytes. Br J Haematol 1988; 70: 441-448.

60. Greinacher A, Nieuwenhuis HK, White JG. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut 1990; 61: 282-288.

61. Young G, Luban NL, White JG. Sebastian syndrome: case report and review of the literature. Am J Hematol 1999; 61: 62-65.

62. Gershoni-Baruch R, Baruch Y, Viener A, Lichtig C. Fechtner syndrome: clinical and genetic aspects. Am J Med Genet 1988; 31: 357-367.

63. Eckstein JD, Filip DJ, Watts JC. Hereditary thrombocytopenia, deafness, and renal disease. Ann Intern Med 1975; 82: 639-645.

64. Standen GR, Saunders J, Michael J, Bloom AL. Epstein’s syndrome: case report and survey of the literature. Postgrad Med J 1987; 63: 573-575.

65. Gilman AL, Sloand E, White JG, Sacher R. A novel hereditary macrothrombocytopenia. J Pediatr Hematol Oncol 1995; 17: 296-305.

66. Drouin A, Favier R, Masse JM, Debili N, Schmitt A, Elbim C, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001; 98: 1382-1391.

67. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007; 21: 21-36.

68. Krishnamurti L, Neglia JP, Nagarajan R, Berry SA, Lohr J, Hirsch B, et al. Paris-Trousseau syndrome platelets in a child with Jacobsen’s syndrome. Am J Hematol 2001; 66: 295-299.

69. Breton-Gorius J, Favier R, Guichard J, Cherif D, Berger R, Debili N, et al. A new congenital dysmegakaryopoietic thrombocytopenia (Paris-Trousseau) associated with giant platelet alpha-granules and chromosome 11 deletion at 11q23. Blood 1995; 85: 1805-1814.

70. Milton JG, Frojmovic MM. Shape-changing agents produce abnormally large platelets in a hereditary «giant platelets syndrome (MPS)». J Lab Clin Med 1979; 93: 154-161.

71. Milton JG, Frojmovic MM, Tang SS, White JG. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS). Am J Pathol 1984; 114: 336-345.

72. Okita JR, Frojmovic MM, Kristopeit S, Wong T, Kunicki TJ. Montreal platelet syndrome: a defect in calcium-activated neutral proteinase (calpain). Blood 1989; 74: 715-721.

73. Smith TP, Dodds WJ, Tartaglia AP. Thrombasthenicthrombopathic thrombocytopenia with giant, «swisscheese» platelets. A case report. Ann Intern Med 1973; 79: 828-834.

74. Green D, Ts’ao CH, Cohen I, Rossi EC. Haemorrhagic thrombocytopathy associated with dilatation of the platelet--membrane complex. Br J Haematol 1981; 48: 595-600.

75. Maldonado JE. Letter: «Swiss-cheese» platelets. Ann Intern Med 1974; 81: 860-861.

76. Cullum C, Cooney DP, Schrier SL. Familial thrombocytopenic thrombocytopathy. Br J Haematol 1967; 13: 147-159.

77. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979; 67: 206-213.

78. Scott syndrome: an inherited defect of the procoagulant activity of platelets. Platelets 1997; 8: 117-124.

79. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2841-2846.

80. Stormorken H, Holmsen H, Sund R, Sakariassen KS, Hovig T, Jellum E, et al. Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality? Thromb Haemost 1995; 74: 1244-1251.

81. Greaves M, Pickering C, Martin J, Cartwright I, Preston FE. A new familial ‘giant platelet syndrome’ with structural, metabolic and functional abnormalities of platelets due to a primary megakaryocyte defect. Br J Haematol 1987; 65: 429-435.

82. Najean Y, Lecompte T. Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases. Br J Haematol 1990; 74: 203-208.

83. Fabris F, Cordiano I, Salvan F, Ramon R, Valente M, Luzzatto G, et al. Chronic isolated macrothrombocytopenia with autosomal dominant transmission: a morphological and qualitative platelet disorder. Eur J Haematol 1997; 58: 40-45.

84. Drouin J, McGregor JL, Parmentier S, Izaguirre CA, Clemetson KJ. Residual amounts of glycoprotein Ib concomitant with near-absence of glycoprotein IX in platelets of Bernard-Soulier patients. Blood 1988; 72: 1086-1088.

85. Andrews RK, Shen Y, Gardiner EE, Dong JF, Lopez JA, Berndt MC. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999; 82: 357-364.

86. Aakhus AM, Stavem P, Hovig T, Pedersen TM, Solum NO. Studies on a patient with thrombocytopenia, giant platelets and a platelet membrane glycoprotein Ib with reduced amount of sialic acid. Br J Haematol 1990; 74: 320-329.

87. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, et al. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibbeta promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996; 271: 22076-22080.

88. Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, et al. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001; 98: 85-92.

89. Yufu Y, Ideguchi H, Narishige T, Suematsu E, Toyoda K, Nishimura J, et al. Familial macrothrombocytopenia associated with decreased glycosylation of platelet membrane glycoprotein IV. Am J Hematol 1990; 33: 271-273.

90. Becker PS, Clavell LA, Beardsley DS. Giant platelets with abnormal surface glycoproteins: a new familial disorder associated with mitral valve insufficiency. J Pediatr Hematol Oncol 1998; 20: 69-73.

91. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 1994; 78: 635-644.

92. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 1980; 55: 243-252.

93. Thrasher AJ, Kinnon C. The Wiskott-Aldrich syndrome. Clin Exp Immunol 2000; 120: 2-9.

94. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006; 117: 725-738; quiz 739.

95. FitzPatrick DR, Strain L, Thomas AE, Barr DG, Todd A, Smith NM, et al. Neurogenic chronic idiopathic intestinal pseudo-obstruction, patent ductus arteriosus, and thrombocytopenia segregating as an X linked recessive disorder. J Med Genet 1997; 34: 666-669.

96. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 1994; 125: 876-885.

97. Campuzano-Maya G. Semiología del hemograma. Laboratorio al Día 1995; 5: 161-174.

98. Haddad E, Cramer E, Riviere C, Rameau P, Louache F, Guichard J, et al. The thrombocytopenia of Wiskott-Aldrich syndrome is not related to a defect in proplatelet formation. Blood 1999; 94: 509-518.

99. Qasim W, Gilmour KC, Heath S, Ashton E, Cranston T, Thomas A, et al. Protein assays for diagnosis of Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Br J Haematol 2001; 113: 861-865.

100. Knox-Macaulay HH, Bashawri L, Davies KE. X linked recessive thrombocytopenia. J Med Genet 1993; 30: 968-969.

101. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32-38.

102. Bessman JD. The relation of megakaryocyte ploidy to platelet volume. Am J Hematol 1984; 16: 161-170.

103. Campuzano-Maya G. Estudio de la medula ósea. Laboratorio al Día 1995; 5: 295-311.

104. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood 1990; 76: 871-881.

105. Lindenbaum J, Hargrove RL. Thrombocytopenia in alcoholics. Ann Intern Med 1968; 68: 526-532.

106. Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol 1992; 98: 502-510.

107. Stoll DB, Blum S, Pasquale D, Murphy S. Thrombocytopenia with decreased megakaryocytes. Evaluation and prognosis. Ann Intern Med 1981; 94: 170-175.

108. Hoffman R, Bruno E, Elwell J, Mazur E, Gewirtz AM, Dekker P, et al. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood 1982; 60: 1173-1178.

109. Chan DK, O’Neill B. Successful trial of antithymocyte globulin therapy in amegakaryocytic thrombocytopenic purpura. Med J Aust 1988; 148: 602-603.

110. Hallett JM, Martell RW, Sher C, Jacobs P. Amegakaryocytic thrombocytopenia with duplication of part of the long arm of chromosome 3. Br J Haematol 1989; 71: 291-292.

111. Nagasawa T, Sakurai T, Kashiwagi H, Abe T. Cell-mediated amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus. Blood 1986; 67: 479-483.

112. Koduri PR. Amegakaryocytic thrombocytopenia with a positive direct Coombs’ test. Am J Hematol 1993; 44: 68-69.

113. Font J, Nomdedeu B, Martinez-Orozco F, Ingelmo M, Balcells A. Amegakaryocytic thrombocytopenia and an analgesic. Ann Intern Med 1981; 95: 783.

114. Telek B, Kiss A, Pecze K, Ujhelyi P, Rak K. Cyclic idiopathic pure acquired amegakaryocytic thrombocytopenic purpura: a patient treated with cyclosporin A. Br J Haematol 1989; 73: 128-129.

115. Kashyap R, Choudhry VP, Pati HP. Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case report. Am J Hematol 1999; 60: 225-228.

116. Hoffman R, Zaknoen S, Yang HH, Bruno E, LoBuglio AF, Arrowsmith JB, et al. An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura. N Engl J Med 1985; 312: 1170-1174.

117. Mukai HY, Kojima H, Todokoro K, Tahara T, Kato T, Hasegawa Y, et al. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thromb Haemost 1996; 76: 675-678.

118. Sandoval C. Thrombocytosis in children with iron deficiency anemia: series of 42 children. J Pediatr Hematol Oncol 2002; 24: 593.

119. Gross S, Keefer V, Newman AJ. The Platelets in Iron- Deficiency Anemia. I. the Response to Oral and Parenteral Iron. Pediatrics 1964; 34: 315-323.

120. Lopas H, Rabiner SF. Thrombocytopenia associated with iron deficiency anemia. A report of five cases. Clin Pediatr (Phila) 1966; 5: 609-616.

121. Dincol K, Aksoy M. On the platelet levels in chronic iron deficiency anemia. Acta Haematol 1969; 41: 135-143.

122. Knizley H, Jr., Noyes WD. Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis. Arch Intern Med 1972; 129: 483-486.

123. Scher H, Silber R. Letter: Iron responsive thrombocytopenia. Ann Intern Med 1976; 84: 571-572.

124. Michaeli J, Admon D, Lugassy G, Matzner Y. Idiopathic thrombocytopenic purpura presenting as iron-responsive thrombocytopenia. Haemostasis 1987; 17: 105-108.

125. Berger M, Brass LF. Severe thrombocytopenia in iron deficiency anemia. Am J Hematol 1987; 24: 425-428.

126. Soff GA, Levin J. Thrombocytopenia associated with repletion of iron in iron-deficiency anemia. Am J Med Sci 1988; 295: 35-39.

127. Go RS, Porrata LF, Call TG. Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency anemia. Ann Intern Med 2000; 132: 925.

128. Beguin Y. Erythropoietin and platelet production. Haematologica 1999; 84: 541-547.

129. Cowan DH. Effect of alcoholism on hemostasis. Semin Hematol 1980; 17: 137-147.

130. Post RM, Desforges JF. Thrombocytopenia and alcoholism. Ann Intern Med 1968; 68: 1230-1236.

131. Lindenbaum J, Lieber CS. Hematologic effects of alcohol in man in the absence of nutritional deficiency. N Engl J Med 1969; 281: 333-338.

132. Ryback R, Desforges J. Alcoholic thrombocytopenia in three inpatient drinking alcoholics. Arch Intern Med 1970; 125: 475-477.

133. Cowan DH, Hines JD. Thrombocytopenia of severe alcoholism. Ann Intern Med 1971; 74: 37-43.

134. Haselager EM, Vreeken J. Rebound thrombocytosis after alcohol abuse: a possible factor in the pathogenesis of thromboembolic disease. Lancet 1977; 1: 774-775.

135. Numminen H, Hillbom M, Juvela S. Platelets, alcohol consumption, and onset of brain infarction. J Neurol Neurosurg Psychiatry 1996; 61: 376-380.

136. Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci 2000; 319: 343-352.

137. Bessman JD, Gilmer PR, Jr., Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol 1983; 80: 322-326.

138. Gewirtz AM, Hoffman R. Transitory hypomegakaryocytic thrombocytopenia: aetiological association with ethanol abuse and implications regarding regulation of human megakaryocytopoiesis. Br J Haematol 1986; 62: 333-344.

139. Levine RF, Spivak JL, Meagher RC, Sieber F. Effect of ethanol on thrombopoiesis. Br J Haematol 1986; 62: 345-354.

140. Cowan DH. Thrombokinetic studies in alcohol-related thrombocytopenia. J Lab Clin Med 1973; 81: 64-76.

141. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.

142. Letsky EA, Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol 1996; 95: 21-26.

143. McMillan R. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes. J Pediatr Hematol Oncol 2003; 25 Suppl 1: S57-61.

144. McMillan R, Longmire RL, Yelenosky R, Smith RS, Craddock CG. Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura. N Engl J Med 1972; 286: 681-684.

145. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL, Jr. Platelet-associated and plasma antiglycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040-1045.

146. Van Vliet HH, Kappers-Klunne MC, van der Hel JW, Abels J. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura. Br J Haematol 1987; 67: 103-108.

147. Zucker-Franklin D, Karpatkin S. Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura. N Engl J Med 1977; 297: 517-523.

148. Campuzano-Maya G, Restrepo MA. Púrpura trombocitopénico idiopático (PTI). Estudio en 96 casos y revisión del tema. Antioquia Médica 1975; 25: 85-99.

149. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood 1984; 64: 1179-1183.

150. Young N, Mortimer P. Viruses and bone marrow failure. Blood 1984; 63: 729-737.

151. Verdonck LF, van Heugten H, de Gast GC. Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infection. Blood 1985; 66: 921-925.

152. Wyler DC, Butterton JR. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1989. A 40-year-old man with headache, fever, rash, and thrombocytopenia after a Caribbean trip. N Engl J Med 1989; 321: 957-965.

153. Flanagan NG, Rowlands AJ, Sloan ME, Ridway JC. Infectious mononucleosis with acute thrombocytopenia. J Infect 1989; 19: 61-63.

154. MacGowan JR, Mahendra P, Ager S, Marcus RE. Thrombocytopenia and spontaneous rupture of the spleen associated with infectious mononucleosis. Clin Lab Haematol 1995; 17: 93-94.

155. Mayer JL, Beardsley DS. Varicella-associated thrombocytopenia: autoantibodies against platelet surface glycoprotein V. Pediatr Res 1996; 40: 615-619.

156. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J 1996; 15: 88-90.

157. Segata M, Chaoui R, Khalek N, Bahado-Singh R, Paidas MJ, Mari G. Fetal thrombocytopenia secondary to parvovirus infection. Am J Obstet Gynecol 2007; 196: 61 e61-64.

158. Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician 2002; 66: 2113-2120.

159. Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol 2003; 55: 107-111.

160. Winiarski J. Mechanisms in childhood idiopathic thrombocytopenic purpura (ITP). Acta Paediatr Suppl 1998; 424: 54-56.

161. Taub JW, Warrier I, Holtkamp C, Beardsley DS, Lusher JM. Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol 1995; 48: 104-107.

162. Hoyle C, Darbyshire P, Eden OB. Idiopathic thrombocytopenia in childhood. Edinburgh experience 1962-82. Scott Med J 1986; 31: 174-179.

163. Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K, et al. Immune thrombocytopenic purpura in childhood in Norway: a prospective, populationbased registration. Pediatr Hematol Oncol 2000; 17: 551-558.

164. Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med 1998; 152: 345-347.

165. Berchtold P, McMillan R, Tani P, Sommerville-Nielsen S, Blanchette VS. Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura. Blood 1989; 74: 1600-1602.

166. Lightsey AL, Jr., Koenig HM, McMillan R, Stone JR, Jr. Platelet-associated immunoglobulin G in childhood idiopathic thrombocytopenic purpura. J Pediatr 1979; 94: 201-204.

167. Ware R, Kinney TR, Friedman HS, Falletta JM, Rosse WF. Prognostic implications for direct platelet-associated IgG in childhood idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 1986; 8: 32-37.

168. McIntosh S, Johnson C, Hartigan P, Baumgarten A, Dwyer JM. Immunoregulatory abnormalities in children with thrombocytopenic purpura. J Pediatr 1981; 99: 525-530.

169. Zimmerman SA, Ware RE. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 1997; 19: 297-303.

170. Sainio S, Kekomaki R, Riikonen S, Teramo K. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 2000; 79: 744-749.

171. Boehlen F, Hohlfeld P, Extermann P, Perneger TV, de Moerloose P. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol 2000; 95: 29-33.

172. Crowther MA, Burrows RF, Ginsberg J, Kelton JG. Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Rev 1996; 10: 8-16.

173. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000; 37: 275-289.

174. Johnson JR, Samuels P. Review of autoimmune thrombocytopenia: pathogenesis, diagnosis, and management in pregnancy. Clin Obstet Gynecol 1999; 42: 317-326.

175. McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev 2003; 17: 7-14.

176. Boehlen F, Hohlfeld P, Extermann P, de Moerloose P. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet Gynecol 1999; 93: 169-173.

177. Levy JA, Murphy LD. Thrombocytopenia in pregnancy. J Am Board Fam Pract 2002; 15: 290-297.

178. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 1993; 48: 781-788.

179. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 1990; 323: 229-235.

180. McCrae KR, Samuels P, Schreiber AD. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 1992; 80: 2697-2714.

181. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993; 329: 1463-1466.

182. Harrington WJ, Sprague CC, Minnich V, Moore CV, Aulvin RC, Dubach R. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 1953; 38: 433-469.

183. Shulman NR, Aster RH, Pearson HA, Hiller MC. Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system. J Clin Invest 1962; 41: 1059-1069.

184. Kunicki TJ, Beardsley DS. The alloimmune thrombocytopenias: neonatal alloimmune thrombocytopenic purpura and post-transfusion purpura. Prog Hemost Thromb 1989; 9: 203-232.

185. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1: 363-366.

186. Kaplan C, Morel-Kopp MC, Kroll H, Kiefel V, Schlegel N, Chesnel N, et al. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991; 78: 425-429.

187. Blanchette VS, Chen L, de Friedberg ZS, Hogan VA, Trudel E, Decary F. Alloimmunization to the PlA1 platelet antigen: results of a prospective study. Br J Haematol 1990; 74: 209-215.

188. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Durand-Zaleski I, Tchernia G. Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood 1997; 89: 4402-4406.

189. Sainio S, Jarvenpaa AL, Renlund M, Riikonen S, Teramo K, Kekomaki R. Thrombocytopenia in term infants: a population-based study. Obstet Gynecol 2000; 95: 441-446.

190. Berkowitz RL, Bussel JB, McFarland JG. Alloimmune thrombocytopenia: state of the art 2006. Am J Obstet Gynecol 2006; 195: 907-913.

191. Pearson HA, Shulman NR, Marder VJ, Cone TE, Jr. Isoimmune Neonatal Thrombocytopenic Purpura. Clinical and Therapeutic Considerations. Blood 1964; 23: 154-177.

192. Go RS. Idiopathic cyclic thrombocytopenia. Blood Rev 2005; 19: 53-59.

193. Tomer A, Schreiber AD, McMillan R, Cines DB, Burstein SA, Thiessen AR, et al. Menstrual cyclic thrombocytopenia. Br J Haematol 1989; 71: 519-524.

194. Yanabu M, Nomura S, Fukuroi T, Kawakatsu T, Kido H, Yamaguchi K, et al. Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia. Acta Haematol 1993; 89: 155-159.

195. Kimura F, Nakamura Y, Sato K, Wakimoto N, Kato T, Tahara T, et al. Cyclic change of cytokines in a patient with cyclic thrombocytopenia. Br J Haematol 1996; 94: 171-174.

196. Kojima K, Fujii N, Omoto E, Nose S, Yoneyama M, Sugii Y, et al. Cyclic thrombocytopenia and polycythemia vera. Ann Hematol 2003; 82: 61-63.

197. Go RS, Lovrich SD, Callister SM, Meyer LA, Bottner WA, Farnen JP. Human cyclic thrombocytopenia and Anaplasma spp. infection. Eur J Haematol 2005; 74: 182-183.

198. Asaumi N, Niiya K, Yoshida C, Shibakura M, Niiya M, Tanimoto M. Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication. Blood Coagul Fibrinolysis 2004; 15: 439-440.

199. Kaptan K, Beyan C. Is complete remission of cyclic thrombocytopenia related to correction of cobalamin deficiency due to H. pylori eradication? Blood Coagul Fibrinolysis 2005; 16: 89; author reply 89.

200. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin-America. Helicobacter 2007; 12: 265-273.

201. Norton A, Roberts I. Management of Evans syndrome. Br J Haematol 2006; 132: 125-137.

202. Hedge UM, Zuiable A, Ball S, Roter BL. The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: a clinical and serological evaluation in 508 patients. Clin Lab Haematol 1985; 7: 7-16.

203. Horino T, Sasaoka A, Takao T, Taguchi T, Maruyama H, Ito H, et al. Immune thrombocytopenic purpura associated with rheumatoid arthritis: case report. Clin Rheumatol 2005; 24: 641-644.

204. Okamoto H, Soejima M, Takeuchi M, Tateishi M, Terai C, Hara M, et al. Dermatomyositis associated with autoimmune idiopathic thrombocytopenia and anti-Ku antibody. Mod Rheumatol 2004; 14: 187-190.

205. Ivey KJ, Hwang YF, Sheets RF. Scleroderma associated with thrombocytopenia and Coombs-positive hemolytic anemia. Am J Med 1971; 51: 815-817.

206. D’Angelo R, Miller R. Pregnancy complicated by severe preeclampsia and thrombocytopenia in a patient with scleroderma. Anesth Analg 1997; 85: 839-841.

207. Kamada K, Kobayashi Y, Katada K, Takahashi Y, Chikayama S, Ikeda M, et al. Scleroderma associated with anemia and thrombocytopenia that responded well to cyclosporin. Acta Haematol 2000; 104: 106-109.

208. Hamaguchi M, Kawahito Y, Ishino H, Yoshida M, Yoshikawa T. A case report of tumor necrosis factor-alpha antibody-induced thrombocytopenia associated with emerging IgM anticardiolipin antibody in patients with scleroderma overlap/rheumatoid arthritis. Clin Rheumatol 2006;

209. Klepfish A, Friedman J, Schechter Y, Schattner A. Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjögren’s syndrome. Rheumatology (Oxford) 2001; 40: 948-949.

210. Jacobs P, Majoos F, Perrotta A. Hyperthyroidism and immune thrombocytopenia. Postgrad Med J 1984; 60: 657-661.

211. Cruz AA, de Alencar VM, Falcao MF, Elias J, Jr., Chahud F. Association between Erdheim-Chester disease, Hashimoto thyroiditis, and familial thrombocytopenia. Ophthal Plast Reconstr Surg 2006; 22: 60-62.

212. Kosmo MA, Bordin G, Tani P, McMillan R. Immune thrombocytopenia and Crohn’s disease. Ann Intern Med 1986; 104: 136.

213. Boyne MS, Dye KR. Crohn’s colitis and idiopathic thrombocytopenic purpura. Postgrad Med J 2000; 76: 299-300.

214. Kahn O, Fiel MI, Janowitz HD. Celiac sprue, idiopathic thrombocytopenic purpura, and hepatic granulomatous disease. An autoimmune linkage? J Clin Gastroenterol 1996; 23: 214-216.

215. Takahashi T, Saitoh T, Imai K. Idiopathic thrombocytopenic purpura complicated with asymptomatic primary biliary cirrhosis. J Gastroenterol 2001; 36: 214-215.

216. Kihara S, Matsuzawa Y, Kubo M, Nozaki S, Funahashi T, Yamashita S, et al. Autoimmune hyperchylomicronemia. N Engl J Med 1989; 320: 1255-1259.

217. Taylor G, Venning V, Wojnarowska F. Bullous pemphigoid and associated autoimmune thrombocytopenia: two case reports. J Am Acad Dermatol 1993; 29: 900-902.

218. Karpatkin S, Strick N, Karpatkin MB, Siskind GW. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 1972; 52: 776-785.

219. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, et al. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 1997; 98: 336-341.

220. Miller MH, Urowitz MB, Gladman DD. The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis Rheum 1983; 26: 1181-1186.

221. Kurata Y, Hayashi S, Kosugi S, Kashiwagi H, Tomiyama Y, Kanayama Y, et al. Elevated platelet-associated IgG in SLE patients due to anti-platelet autoantibody: differentiation between autoantibodies and immune complexes by ether elution. Br J Haematol 1993; 85: 723-728.

222. Kalunian KC, Peter JB, Middlekauff HR, Sayre J, Ando DG, Mangotich M, et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988; 85: 602-608.

223. Khamashta MA, Harris EN, Gharavi AE, Derue G, Gil A, Vazquez JJ, et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849-854.

224. Nojima J, Suehisa E, Kuratsune H, Machii T, Toku M, Tada H, et al. High prevalence of thrombocytopenia in SLE patients with a high level of anticardiolipin antibodies combined with lupus anticoagulant. Am J Hematol 1998; 58: 55-60.

225. Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian Registry. Italian Registry of Antiphospholipid Antibodies (IR-APA). Haematologica 1993; 78: 313-318.

226. Cuadrado MJ, Mujic F, Munoz E, Khamashta MA, Hughes GR. Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis 1997; 56: 194-196.

227. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: 4120-4124.

228. Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H, et al. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol 1985; 59: 231-234.

229. Schultz DR. Antiphospholipid antibodies: basic immunology and assays. Semin Arthritis Rheum 1997; 26: 724-739.

230. Rueda E, Mendez A, Gonzalez G. [Hemophagocytic syndrome associated with dengue hemorrhagic fever]. Biomedica 2002; 22: 160-166.

231. Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep 2005; 4: 145-148.

232. Wichmann O, Gascon J, Schunk M, Puente S, Siikamaki H, Gjorup I, et al. Severe dengue virus infection in travelers: risk factors and laboratory indicators. J Infect Dis 2007; 195: 1089-1096.

233. von Landenberg P, Lehmann HW, Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 2007; 6: 278-285.

234. Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr 1993; 82: 267-270.

235. McClure PD. Idiopathic thrombocytopenic purpura in children: diagnosis and management. Pediatrics 1975; 55: 68-74.

236. Carter RL. Platelet levels in infectious mononucleosis. Blood 1965; 25: 817-821.

237. Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, et al. Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med 1989; 150: 170-173.

238. Walsh C, Krigel R, Lennette E, Karpatkin S. Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 542-545.

239. Campuzano-Maya G. Aspectos hematológicos en el paciente infectado por el VIH. Fundamentos de Medicina. SIDA Enfoque Integral. CIB. 1996; 134-148.

240. Matsuoka T, Tamura H, Fujishita M, Kubonishi I, Taguchi H, Miyoshi I. Thrombocytopenic purpura in a carrier of human T-cell leukemia virus type I. Am J Hematol 1988; 27: 142-143.

241. Karpatkin S, Nardi MA, Hymes KB. Immunologic thrombocytopenic purpura after heterosexual transmission of human immunodeficiency virus (HIV). Ann Intern Med 1988; 109: 190-193.

242. Nardi M, Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med 2000; 191: 2093-2100.

243. Carey PJ. Drug-induced myelosuppression : diagnosis and management. Drug Saf 2003; 26: 691-706.

244. Torres JR, Torres-Viera MA, Schupbach J, Rangel HR, Pujol FH. Non-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection. J Infect 2007; 54: e21-24.

245. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878.

246. Horstmann RD, Dietrich M, Bienzle U, Rasche H. Malariainduced thrombocytopenia. Blut 1981; 42: 157-164.

247. Grau GE, Piguet PF, Gretener D, Vesin C, Lambert PH. Immunopathology of thrombocytopenia in experimental malaria. Immunology 1988; 65: 501-506.

248. Lee SH, Looareesuwan S, Chan J, Wilairatana P, Vanijanonta S, Chong SM, et al. Plasma macrophage colony-stimulating factor and P-selectin levels in malariaassociated thrombocytopenia. Thromb Haemost 1997; 77: 289-293.

249. Aggarwal A, Rath S, Shashiraj. Plasmodium vivax malaria presenting with severe thrombocytopenia. J Trop Pediatr 2005; 51: 120-121.

250. Antinori S, Galimberti L, Gianelli E, Morelli P, Radice A, Acquaviva V, et al. Thrombocytopenia and Plasmodium vivax malaria. Clin Infect Dis 2005; 41: 1210-1211; author reply 1211-1212.

251. Kumar A, Shashirekha. Thrombocytopenia--an indicator of acute vivax malaria. Indian J Pathol Microbiol 2006; 49: 505-508.

252. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M. Anemia and thrombocytopenia in children with Plasmodium vivax malaria. J Trop Pediatr 2006; 52: 49-51.

253. Kaur D, Wasir V, Gulati S, Bagga A. Unusual presentation of Plasmodium vivax malaria with severe thrombocytopenia and acute renal failure. J Trop Pediatr 2007 (Epub ahead of print).

254. Moerman F, Colebunders B, D’Alessandro U. Thrombocytopenia in African children can predict the severity of malaria caused by Plasmodium falciparum and the prognosis of the disease. Am J Trop Med Hyg 2003; 68: 379; author reply 380-371.

255. Hamblin TJ, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 1986; 39: 713-716.

256. Wajima T. Spontaneous regression of chronic lymphocytic leukemia and simultaneous development of autoimmune hemolytic anemia and autoimmune thrombocytopenia. Am J Hematol 2000; 65: 88-89.

257. Wells T, Kovacs MJ. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine. Ann Pharmacother 2003; 37: 671-674.

258. Visco C, Giaretta I, Ruggeri M, Madeo D, Tosetto A, Rodeghiero F. Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia 2007;

259. Gupta V, Hegde UM, Parameswaran R, Newland AC. Multiple myeloma and immune thrombocytopenia. Clin Lab Haematol 2000; 22: 239-242.

260. Bradley SJ, Hudson GV, Linch DC. Idiopathic thrombocytopenic purpura in Hodgkin’s disease: a report of eight cases. Clin Oncol (R Coll Radiol) 1993; 5: 355-357.

261. Kondo H, Oyamada T, Mori A, Sumi H, Kurosu K, Kajii E, et al. Direct-antiglobulin-test-negative immune haemolytic anaemia and thrombocytopenia in a patient with Hodgkin’s disease. Acta Haematol 2001; 105: 233-236.

262. Bachmeyer C, Audouin J, Bouillot JL, Coutarel P, Mougeot-Martin M, Delmer A. Immune thrombocytopenic purpura as the presenting feature of gastric MALT lymphoma. Am J Gastroenterol 2000; 95: 1599-1600.

263. Mueller-Eckhardt C. Post-transfusion purpura. Br J Haematol 1986; 64: 419-424.

264. Ballem PJ, Buskard NA, Decary F, Doubroff P. Posttransfusion purpura secondary to passive transfer of anti-P1A1 by blood transfusion. Br J Haematol 1987; 66: 113-114.

265. Nijjar TS, Bonacosa IA, Israels LG. Severe acute thrombocytopenia following infusion of plasma containing anti P1A1. Am J Hematol 1987; 25: 219-221.

266. Scott EP, Moilan-Bergeland J, Dalmasso AP. Posttransfusion thrombocytopenia associated with passive transfusion of a platelet-specific antibody. Transfusion 1988; 28: 73-76.

267. Warkentin TE, Smith JW, Hayward CP, Ali AM, Kelton JG. Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b). Blood 1992; 79: 2480-2484.

268. Brunner-Bolliger S, Kiefel V, Horber FF, Nydegger UE, Berchtold P. Antibody studies in a patient with acute thrombocytopenia following infusion of plasma containing anti-PI(A1). Am J Hematol 1997; 56: 119-121.

269. Morishita K, Wakamoto S, Miyazaki T, Sato S, Fujihara M, Kaneko S, et al. Life-threatening adverse reaction followed by thrombocytopenia after passive transfusion of fresh frozen plasma containing anti-CD36 (Nak) isoantibody. Transfusion 2005; 45: 803-806.

270. Novotny VM, van Doorn R, Witvliet MD, Claas FH, Brand A. Occurrence of allogeneic HLA and non-HLA antibodies after transfusion of prestorage filtered platelets and red blood cells: a prospective study. Blood 1995; 85: 1736-1741.

271. Schiffer CA. Diagnosis and management of refractoriness to platelet transfusion. Blood Rev 2001; 15: 175-180.

272. Rebulla P. Refractoriness to platelet transfusion. Curr Opin Hematol 2002; 9: 516-520.

273. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-4114.

274. Nakazawa Y, Saito S, Hasegawa Y, Yanagisawa R, Sakashita K, Kamijo T, et al. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia. Transfusion 2007; 47: 326-334.

275. West KA, Anderson DR, McAlister VC, Hewlett TJ, Belitsky P, Smith JW, et al. Alloimmune thrombocytopenia after organ transplantation. N Engl J Med 1999; 341: 1504-1507.

276. Panzer S, Kiefel V, Bartram CR, Haas OA, Hinterberger W, Mueller-Eckhardt C, et al. Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-PlA1 specificity: evidence for a host-derived immune reaction. Br J Haematol 1989; 71: 259-264.

277. Bierling P, Pignon JM, Kuentz M, Mitjavila MT, Fromont P, Barbu V, et al. Thrombocytopenia after bone marrow transplantation caused by a recipient origin Br(a) allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapse. Blood 1994; 83: 274-279.

278. Talaulikar D, Falk M, Talaulikar G, Pidcock M. Immune thrombocytopenia after renal transplantation for IgA nephropathy. Acta Haematol 2007; 117: 65-67.

279. Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 2006; 38: 377-384.

280. Thomas-Kaskel AK, Mattern D, Kohler G, Finke J, Behringer D. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation. Cytometry B Clin Cytom 2007;

281. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985; 65: 368-374.

282. Minchinton RM, Waters AH, Malpas JS, Starke I, Kendra JR, Barrett AJ. Platelet- and granulocyte-specific antibodies after allogeneic and autologous bone marrow grafts. Vox Sang 1984; 46: 125-135.

283. Chan EY, Lawton JW, Lie AK, Lau CS. Autoantibody formation after allogeneic bone marrow transplantation: correlation with the reconstitution of CD5+ B cells and occurrence of graft-versus-host disease. Pathology 1997; 29: 184-188.

284. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054-1058.

285. Madaio MP, Spiegel JE, Levey AS. Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Evidence of in situ immune complex formation on the platelet surface. Transplantation 1988; 45: 647-649.

286. Hong JC, Kahan BD. Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management. Transplantation 2000; 69: 2085-2090.

287. Hackett T, Kelton JG, Powers P. Drug-induced platelet destruction. Semin Thromb Hemost 1982; 8: 116-137.

288. Kaufman DW, Kelly JP, Johannes CB, Sandler A, Harmon D, Stolley PD, et al. Acute thrombocytopenic purpura in relation to the use of drugs. Blood 1993; 82: 2714-2718.

289. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med 1998; 129: 886-890.

290. Pedersen-Bjergaard U, Andersen M, Hansen PB. Druginduced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 1997; 52: 183-189.

291. Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999; 36: 2-6.

292. Greinacher A, Eichler P, Lubenow N, Kiefel V. Drug-induced and drug-dependent immune thrombocytopenias. Rev Clin Exp Hematol 2001; 5: 166-200; discussion 311-162.

293. Warkentin TE. Drug-induced immune-mediated thrombocytopenia--from purpura to thrombosis. N Engl J Med 2007; 356: 891-893.

294. Neely SM, Gardner DV, Reynolds N, Green D, Ts’ao CH. Mechanism and characteristics of platelet activation by haematin. Br J Haematol 1984; 58: 305-316.

295. Gangarosa EJ, Johnson TR, Ramos HS. Ristocetin-induced thrombocytopenia: site and mechanism of action. Arch Intern Med 1960; 105: 83-89.

296. Green D, Tuite GF, Jr. Declining platelet counts and platelet aggregation during porcine VIII:C infusions. Am J Med 1989; 86: 222-224.

297. Blendis LM, Smith PM, Lawrie BW, Stephens MR, Evans WD. Portal hypertension in vinyl chloride monomer workers. A hemodynamic study. Gastroenterology 1978; 75: 206-211.

298. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325-345.

299. Scott JM, Weir DG. Drug-induced megaloblastic change. Clin Haematol 1980; 9: 587-606.

300. Van den Bemt PM, Meyboom RH, Egberts AC. Druginduced immune thrombocytopenia. Drug Saf 2004; 27: 1243-1252.

301. Fabris F, Luzzatto G, Stefani PM, Girolami B, Cella G, Girolami A. Heparin-induced thrombocytopenia. Haematologica 2000; 85: 72-81.

302. Arepally GM, Ortel TL. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 2006; 355: 809-817.

303. Daneschvar HL, Daw H. Heparin-induced thrombocytopenia (an overview). Int J Clin Pract 2007; 61: 130-137.

304. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000; 96: 1703-1708.

305. Warkentin TE, Kelton JG. Heparin and platelets. Hematol Oncol Clin North Am 1990; 4: 243-264.

306. Heeger PS, Backstrom JT. Heparin flushes and thrombocytopenia. Ann Intern Med 1986; 105: 143.

307. Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia. Blood 2003; 101: 3049-3051.

308. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.

309. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100: 535-540.

310. Bell WR, Royall RM. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980; 303: 902-907.

311. Shorten GD, Comunale ME. Heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 1996; 10: 521-530.

312. Kelton JG. The clinical management of heparin-induced thrombocytopenia. Semin Hematol 1999; 36: 17-21.

313. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest 2005; 127: 1857-1861.

314. Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449-1459.

315. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996; 101: 502-507.

316. Cancio LC, Cohen DJ. Heparin-induced thrombocytopenia and thrombosis. J Am Coll Surg 1998; 186: 76-91.

317. Kelton JG, Smith JW, Warkentin TE, Hayward CP, Denomme GA, Horsewood P. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83: 3232-3239.

318. Amiral J. Antigens involved in heparin-induced thrombocytopenia. Semin Hematol 1999; 36: 7-11.

319. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.

320. Koornstra JJ, Loualidi A, de Vries CJ. Ticlopidine-induced thrombocytopenia. Neth J Med 1999; 54: 73-75.

321. Briguori C, Manganelli F, Picardi M, Villari B, Ricciardelli B. Thrombocytopenia and purpura-like lesions associated with clopidogrel. Ital Heart J 2001; 2: 935-937.

322. Nishigaki F, Tsujimoto S, Inami M, Matsumoto S, Naoe Y, Kawamura I, et al. Effects of a novel pyridylsulphonyl thiazole derivative, FR115092, on autoimmune and mitomycin C-induced thrombocytopenia in mice. J Pharm Pharmacol 1999; 51: 857-865.

323. Her MY, Kim TH, Chang HK, Lee WS, Yoo DH. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still’s disease. Rheumatol Int 2007; 27: 295-298.

324. Reid DW, Street A, Mansfield D, Chin W, Cole-Sinclair M, Williams TJ, et al. Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy. Respirology 2003; 8: 243-245.

325. Groneberg DA, Barkhuizen A, Jeha T. Simvastatin-induced thrombocytopenia. Am J Hematol 2001; 67: 277.

326. Harrison EE, Hickman JW. Hemolytic anemia and thrombocytopenia associated with penicillamine ingestion. South Med J 1975; 68: 113-115.

327. Parker JC, Barrett DA, 2nd. Microangiopathic hemolysis and thrombocytopenia related to penicillin drugs. Arch Intern Med 1971; 127: 474-477.

328. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-1935.

329. Terrell DR, Williams LA, Vesely SK, Lammle B, Hovinga JA, George JN. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 2005; 3: 1432-1436.

330. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the lit-erature. Medicine (Baltimore) 1966; 139-159.

331. George JN, Vesely SK, Terrell DR. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. 2004; 41: 60-67.

332. McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpurahemolytic uremic syndrome during pregnancy. J Clin Apher 2001; 16: 202-209.

333. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60-68.

334. Burns ER, Lou Y, Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol 2004; 75: 18-21.

335. Sadler JE. Thrombotic thrombocytopenic purpura: a moving target. Hematology Am Soc Hematol Educ Program 2006; 415-420.

336. Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002; 8: 1-31.

337. Toh CH, Dennis M. Current clinical practice. DIC 2002: a review of disseminated intravascular coagulation. Hematology 2003; 8: 65-71.

338. Frevel T, Rabe H, Uckert F, Harms E. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review. Eur J Pediatr 2002; 161: 243-246.

339. Mukhtar IA, Letts M. Hemangioma of the radius associated with Kasabach-Merritt syndrome: case report and literature review. J Pediatr Orthop 2004; 24: 87-91.

340. Straub PW, Kessler S, Schreiber A, Frick PG. Chronic intravascular coagulation in Kasabach-Merritt syndrome. Preferential accumulation of fibrinogen 131 I in a giant hemangioma. Arch Intern Med 1972; 129: 475-478.

341. Aboulafia DM, Aboulafia ED. Aortic aneurysm-induced disseminated intravascular coagulation. Ann Vasc Surg 1996; 10: 396-405.

342. Lowe EJ, Werner EJ. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents. Semin Thromb Hemost 2005; 31: 717-730.

343. Franchini M, Zaffanello M, Veneri D. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Res 2006; 118: 177-184.

344. Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006; 70: 423-431.

345. Banatvala N, Griffin PM, Greene KD, Barrett TJ, Bibb WF, Green JH, et al. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, erologic, clinical, and epidemiologic findings. J Infect Dis 2001; 183: 1063-1070.

346. Higgins JR, de Swiet M. Blood-pressure measurement and classification in pregnancy. Lancet 2001; 357: 131-135.

347. Gibson B, Hunter D, Neame PB, Kelton JG. Thrombocytopenia in preeclampsia and eclampsia. Semin Thromb Hemost 1982; 8: 234-247.

348. Burrows RF, Hunter DJ, Andrew M, Kelton JG. A prospective study investigating the mechanism of thrombocytopenia in preeclampsia. Obstet Gynecol 1987; 70: 334-338.

349. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142: 159-167.

350. Minakami H, Kohmura Y, Izumi A, Watanabe T, Matsubara S, Sato I. Relation between gestational thrombocytopenia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome). Gynecol Obstet Invest 1998; 46: 41-45.

351. Vigil-de Gracia P. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int J Gynaecol Obstet 2001; 72: 17-23.

352. Usta IM, Sibai BM. Acute fatty liver of pregnancy. J Med Liban 1995; 43: 186-193.

353. Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999; 181: 389-395.

354. Mjahed K, Charra B, Hamoudi D, Noun M, Barrou L. Acute fatty liver of pregnancy. Arch Gynecol Obstet 2006; 274: 349-353.

355. Bacq Y. Acute fatty liver of pregnancy. Semin Perinatol 1998; 22: 134-140.

356. Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol 2006; 12: 7397-7404.

357. Goldenfarb PB, Zucker S, Corrigan JJ, Jr., Cathey MH. The coagulation mechanism in acute bacterial infection. Br J Haematol 1970; 18: 643-652.

358. Svanbom M. A prospective study on septicemia. II. Clinical manifestations and complications, results of antimicrobial treatment and report of a follow-up study. Scand J Infect Dis 1980; 12: 189-206.

359. Neame PB, Kelton JG, Walker IR, Stewart IO, Nossel HL, Hirsh J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980; 56: 88-92.

360. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68: 344-355.

361. Corrigan JJ, Jr., Jordan CM. Heparin therapy in septicemia with disseminated intravascular coagulation. N Engl J Med 1970; 283: 778-782.

362. Oppenheimer L, Hryniuk WM, Bishop AJ. Thrombocytopenia in severe bacterial infections. J Surg Res 1976; 20: 211-214.

363. Kestin AS, Valeri CR, Khuri SF, Loscalzo J, Ellis PA, MacGregor H, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-117.

364. Hope AF, Heyns AD, Lotter MG, van Reenen OR, de Kock F, Badenhorst PN, et al. Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1981; 81: 880-886.

365. Bevan DH. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999; 104: 208-219.

366. Gelb AB, Roth RI, Levin J, London MJ, Noall RA, Hauck WW, et al. Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. Am J Clin Pathol 1996; 106: 87-99.

367. Teoh KH, Young E, Bradley CA, Hirsh J. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass. Circulation 1993; 88: II420-425.

368. Harker LA. Platelet and fibrinogen kinetic evaluation of thrombogenesis. Scand J Haematol Suppl 1979; 34: 31-51.

369. Makoni SN. Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature. Heart 2001; 86: E18.

370. Nikolsky E, Sadeghi HM, Effron MB, Mehran R, Lansky AJ, Na Y, et al. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. Am J Cardiol 2005; 96: 474-481.

371. Gupta BK, Savage MP, Brest AN. Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia. Cathet Cardiovasc Diagn 1995; 35: 42-46.

372. Harrington RA, Sane DC, Califf RM, Sigmon KN, Abbottsmith CW, Candela RJ, et al. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1994; 23: 891-898.

373. Joseph T, Marco J, Gregorini L. Acute profound thrombocytopenia after abciximab therapy during coronary angioplasty. Clin Cardiol 1998; 21: 851-852.

374. Gafter U, Bessler H, Malachi T, Zevin D, Djaldetti M, Levi J. Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron 1987; 45: 207-210.

375. Hakim RM, Schafer AI. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 1985; 78: 575-580.

376. Vicks SL, Gross ML, Schmitt GW. Massive hemorrhage due to hemodialysis-associated thrombocytopenia. Am J Nephrol 1983; 3: 30-33.

377. Caffrey EA, Sladen GE, Isaacs PE, Clark KG. Thrombocytopenia caused by cow’s milk. Lancet 1981; 2: 316.

378. Iakovou Y, Manginas A, Melissari E, Cokkinos DV. Acute profound thrombocytopenia associated with anaphylactic reaction after abciximab therapy during percutaneous coronary angioplasty. Cardiology 2001; 95: 215-216.

379. Bush SP, Wu VH, Corbett SW. Rattlesnake venom-induced thrombocytopenia response to Antivenin (Crotalidae) Polyvalent: a case series. Acad Emerg Med 2000; 7: 181-185.

380. Rucavado A, Soto M, Kamiguti AS, Theakston RD, Fox JW, Escalante T, et al. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage. Thromb Haemost 2001; 85: 710-715.

381. Offerman SR, Barry JD, Schneir A, Clark RF. Biphasic rattlesnake venom-induced thrombocytopenia. J Emerg Med 2003; 24: 289-293.

382. Odeleye AA, Presley AE, Passwater ME, Paul DM. Report of two cases: Rattlesnake venom-induced thrombocytopenia. Ann Clin Lab Sci 2004; 34: 467-470.

383. Muguruma T, Koyama T, Kanadani T, Furujo M, Shiraga H, Ichiba Y. Acute thrombocytopenia associated with poststreptococcal acute glomerulonephritis. J Paediatr Child Health 2000; 36: 401-402.

384. Tasic V, Polenakovic M. Thrombocytopenia during the course of acute poststreptococcal glomerulonephritis. Turk J Pediatr 2003; 45: 148-151.

385. Schatken RV. Hypersplenism: a review and case report. Ann Surg 1952; 135: 536-542.

386. Campuzano-Maya G. Hiperesplenismo. Cirugía. Principios Básicos. Editorial Universidad de Antioquia. 1996; 343-369.

387. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 2000; 14 Suppl D: 60D-66D.

388. Shenaq SA, Yawn DH, Saleem A, Joswiak R, Crawford ES. Effect of profound hypothermia on leukocytes and platelets. Ann Clin Lab Sci 1986; 16: 130-133.

389. Bernard SA, Buist M. Induced hypothermia in critical care medicine: a review. Crit Care Med 2003; 31: 2041-2051.

390. Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence. Intensive Care Med 2004; 30: 556-575.

391. Georgiadis D, Schwab S. Hypothermia in Acute Stroke. Curr Treat Options Neurol 2005; 7: 119-127.

392. Cohen IJ, Amir J, Gedaliah A, Rachmal A, Gorodischer R, Zaizov R. Thrombocytopenia of neonatal cold injury. J Pediatr 1984; 104: 620-622.

393. Easterbrook PJ, Davis HP. Thrombocytopenia in hypothermia: a common but poorly recognised complication. Br Med J (Clin Res Ed) 1985; 291: 23.

394. Vella MA, Jenner C, Betteridge DJ, Jowett NI. Hypothermia- induced thrombocytopenia. J R Soc Med 1988; 81: 228-229.

395. Chan KM, Beard K. A patient with recurrent hypothermia associated with thrombocytopenia. Postgrad Med J 1993; 69: 227-229.

396. Balcombe NR. The chilling tale of a patient with thrombocytopenia. Postgrad Med J 1999; 75: 621-623.

397. Holm IA, McLaughlin JF, Feldman K, Stone EF. Recurrent hypothermia and thrombocytopenia after severe neonatal brain infection. Clin Pediatr (Phila) 1988; 27: 326-329.

398. Elfenbein DS, Barness EG, Pomerance HH, Barness LA. Newborn infant with lethargy, poor feeding, dehydration, hypothermia, hyperammonemia, neutropenia, and thrombocytopenia. Am J Med Genet 2000; 94: 332-337.

399. White KD, Scoones DJ, Newman PK. Hypothermia in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 61: 369-375.

400. Hessel EA, 2nd, Schmer G, Dillard DH. Platelet kinetics during deep hypothermia. J Surg Res 1980; 28: 23-34.

401. Bernard SA, Mac CJB, Buist M. Experience with prolonged induced hypothermia in severe head injury. Crit Care (Lond) 1999; 3: 167-172.

402. Qiu WS, Wang WM, Du HY, Liu WG, Shen H, Shen LF, et al. Thrombocytopenia after therapeutic hypothermia in severe traumatic brain injury. Chin J Traumatol 2006; 9: 238-241.

403. Bareford D, Chandler ST, Hawker RJ, Jackson N, Smith M, Boughton BJ. Splenic platelet-sequestration following routine blood transfusion is reduced by filtered/washed blood products. Br J Haematol 1987; 67: 177-180.

404. Lim S, Boughton BJ, Bareford D. Thrombocytopenia following routine blood transfusion: micro-aggregate blood filters prevent worsening thrombocytopenia in patients with low platelet counts. Vox Sang 1989; 56: 40-41.

405. Hart S, Bareford D, Smith N, MacWhannel A, Lanchbury E, Boughton B. Post-transfusion thrombocytopenia: its duration in splenic and asplenic individuals. Vox Sang 1990; 59: 123-124.

406. Copplestone JA. Asymptomatic thrombocytopenia developing during pregnancy (gestational thrombocytopenia)--a clinical study. Q J Med 1992; 84: 593-601.

407. Shehata N, Burrows R, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol 1999; 42: 327-334.

408. Win N, Rowley M, Pollard C, Beard J, Hambley H, Booker M. Severe gestational (incidental) thrombocytopenia: to treat or not to treat. Hematology 2005; 10: 69-72.

409. Tygart SG, McRoyan DK, Spinnato JA, McRoyan CJ, Kitay DZ. Longitudinal study of platelet indices during normal pregnancy. Am J Obstet Gynecol 1986; 154: 883-887.